SCHEMBL7605854

SCHEMBL7605854

Cc1cc(NC(=O)c2ccccc2-c2ccccc2)cc(C(=O)NCc2ccc(-c3ccccc3)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ CHRNB2 P17787 2/20 0.56
▸ CHRNB4 P30926 2/20 0.56
▸ CHRNA3 P32297 2/20 0.56
▸ CHRNA4 P43681 2/20 0.56
▸ PPARG P37231 4/20 0.51
▸ AKR1C4 P17516 2/20 0.49
▸ AKR1C3 P42330 2/20 0.49
▸ AKR1C2 P52895 1/20 0.49
▸ EGFR P00533 1/20 0.49
▸ EPHX2 P34913 1/20 0.49
▸ NR1H4 Q96RI1 1/20 0.49
▸ HTT P42858 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610512 0.87 L3MBTL1 (0.61) L3MBTL1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7611070 0.87 CHRNB2 (0.56) CHRNB2CHRNB4CHRNA3CHRNA4PPARG
SCHEMBL7610932 0.85 CHRNB2 (0.60) L3MBTL1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7610893 0.83 CHRNB2 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4PPARG
SCHEMBL7611172 0.82 HTT (0.57) L3MBTL1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7605010 0.81 CHRNB2 (0.61) L3MBTL1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7607213 0.81 HTT (0.61) L3MBTL1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7611690 0.81 LMNA (0.56) L3MBTL1PPARGAKR1C4AKR1C3AKR1C2
SCHEMBL7616965 0.80 HDAC8 (0.57) CHRNB2CHRNB4CHRNA3CHRNA4PPARG
SCHEMBL7613182 0.79 CHRNB2 (0.57) L3MBTL1CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 L3MBTL1 3333/4885CHRNB2 4877/4885CHRNB4 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback